--- title: "U.S. stock night market opening fluctuations: Moleculin Biotech fell 3.53% in the night market; Replimune fell 3.19% in the night market" type: "News" locale: "en" url: "https://longbridge.com/en/news/294749510.md" description: "Moleculin Biotech fell 3.53% in after-hours trading; Replimune fell 3.19% in after-hours trading; Rain Enhancement Tech Holdco rose 149.37% in after-hours trading; Ameliorate rose 21.07% in after-hours trading; Backblaze rose 16.61% in after-hours trading" datetime: "2026-08-04T00:17:30.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294749510.md) - [en](https://longbridge.com/en/news/294749510.md) - [zh-HK](https://longbridge.com/zh-HK/news/294749510.md) generator: "portal-rs" --- # U.S. stock night market opening fluctuations: Moleculin Biotech fell 3.53% in the night market; Replimune fell 3.19% in the night market **U.S. Stock Night Market Opening Movements** Moleculin Biotech fell 3.53% in the night market. Based on recent key news: 1. On August 1, Moleculin Biotech announced a public offering of approximately 12.38 million shares, along with warrants to purchase up to 37.13 million shares. The purchase price per share for this transaction was $0.75, resulting in a significant drop in stock price of 63.53%. 2. On August 3, website loading issues may have affected investor confidence, further exacerbating stock price volatility. The overall market is quite volatile and requires cautious observation. Replimune fell 3.19% in the night market. Recently, there has been no significant news; trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. no\_news **Top Gainers in the U.S. Night Market** Rain Enhancement Tech Holdco rose 149.37% in the night market, with no significant news recently. Trading is active, and capital flows are evident. Considering the sector and industry trends, the stock shows significant volatility, and specific reasons need further observation. Ameresek rose 21.07% in the night market. Based on recent key news: 1. On August 3, Ameresek announced its second-quarter financial report, with revenue increasing by 9% year-on-year to $515 million, exceeding expectations, and project backlog increasing by 32% to $6.73 billion, driving the stock price up. Source: Reuters 2. On August 3, the company raised its full-year adjusted earnings per share forecast to $1.15-$1.35, exceeding analyst expectations and boosting market confidence. Source: SEC announcement 3. On August 3, Ameresek made progress on data center projects, adding three new projects, further enhancing market expectations for its future growth. Source: Company statement. Strong demand in the energy sector is driving the stock price up. Backblaze rose 16.61% in the night market. Based on recent key news: 1. On August 3, Backblaze announced its second-quarter financial report, with net income and revenue both exceeding expectations. The company reported net income of $0.08 per share, far exceeding the analyst expectation of $0.02, with revenue reaching $42.7 million, surpassing the expected $39.9 million. This news drove the stock price up by 17%. 2. On August 3, Backblaze announced a five-year data storage agreement worth $335 million with CoreWeave. This agreement will significantly enhance the company's market position in the AI object storage sector, further boosting investor confidence. 3. On August 4, Backblaze participated as a platinum sponsor in the Ai4 2026 conference, showcasing its high-throughput object storage technology. This move helps enhance the company's brand awareness and market influence, attracting more potential customers The cloud storage industry is experiencing strong growth, with increasing demand for AI applications ### Related Stocks - [MBRX.US](https://longbridge.com/en/quote/MBRX.US.md) - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) - [RAIN.US](https://longbridge.com/en/quote/RAIN.US.md) - [AMRC.US](https://longbridge.com/en/quote/AMRC.US.md) - [BLZE.US](https://longbridge.com/en/quote/BLZE.US.md) ## Related News & Research - [Moleculin Biotech announces annual shareholder meeting](https://longbridge.com/en/news/296828733.md) - [16:20 ETRobbins LLP Urges REPL Investors Who Lost Money Investing in Replimune to Contact the Firm for Information About Leading the Class Action](https://longbridge.com/en/news/296649920.md) - [BUZZ-AI storage firm Backblaze stabilizes after boosted $175 mln convertible offering](https://longbridge.com/en/news/296479463.md) - [HPE Named a Leader in 2026 Gartner® Magic Quadrant™ for Enterprise Storage Platforms | HPE Stock News](https://longbridge.com/en/news/296635205.md) - [Everpure (P) Named A Gartner Leader For The Second Straight Year](https://longbridge.com/en/news/296688895.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**